Loading clinical trials...
Loading clinical trials...
SSRI Antidepressant Fluoxetine Improving Immunotherapy Efficacy in Advanced Hepatobiliary Malignancy Patients With Depression and Anxiety: A Randomized Controlled Clinical Trial
Conditions
Interventions
Fluoxetine (drug)
Placebo
Locations
1
China
First Affiliated Hospital of Wenzhou Medical University
Wenzhou, Zhejiang, China
Start Date
October 1, 2025
Primary Completion Date
October 1, 2027
Completion Date
December 1, 2027
Last Updated
March 24, 2026
NCT07432945
NCT06661460
NCT07235852
NCT04191811
NCT07153250
NCT05067998
Lead Sponsor
First Affiliated Hospital of Wenzhou Medical University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions